The compliance bill is coming, and it’s landing on two different desks
For the last few years, healthcare organizations have treated AI governance and interoperability requirements as parallel, mostly separate conversations: one for the IT and compliance team, one for whoever is piloting a new clinical tool. That separation is closing fast. Regulators in the US and across major LATAM markets are converging on the same expectation: healthcare AI has to be explainable, auditable, and built on data that can actually move between systems. For hospitals and insurers still treating these as future problems, 2027 is when they become budget line items.
Two mandates, one underlying demand
Interoperability requirements are pushing hospitals and insurers to prove that clinical, administrative, and financial data can be exchanged and reconciled across systems, not just stored. That sounds like an IT problem until you notice that most of the operational inefficiency inside a hospital (delayed discharges, mismatched billing, duplicate testing) exists precisely because those data sources don’t talk to each other today.
AI governance requirements are pushing in a related direction: any model influencing a clinical or financial decision increasingly needs to show why it reached that conclusion, not just what it concluded. Regulators are moving away from accepting “the model is 94% accurate” as sufficient and toward requiring a traceable rationale, particularly for anything touching diagnosis, discharge, or reimbursement decisions.
Put together, both mandates are really asking the same underlying question: can you explain your data and your decisions well enough for an outside party to trust them? That’s a governance question before it’s a technology question, and it’s going to determine who gets audited smoothly and who doesn’t.
What this actually costs, and who pays it
- For hospitals, the exposure sits mostly in documentation and traceability. Payment models based on DRG classification already require clean, standardized case-mix data; interoperability mandates raise the bar further by requiring that data to be exchangeable in a structured, auditable format. Hospitals running on fragmented, retrospective reporting, still the norm today, will face a scramble to retrofit that structure. This is a large part of why Hosdatia was built around a proprietary DRG standardization engine from day one rather than treating it as an add-on: the same infrastructure that anticipates length of stay and bed capacity is the infrastructure that produces defensible, standardized records when a regulator or payer asks for them.
- For insurers, the exposure is heavier on the audit side. Automated underwriting, risk classification, and reimbursement decisions are exactly the kind of AI-driven processes coming under the most governance scrutiny, because they directly affect what a patient or provider gets paid. Insurers that already run continuous, automated audit trails will have a straightforward compliance story. Insurers still relying on periodic manual review will need to build that capability essentially from scratch, under time pressure. Insuria was designed around this exact continuity requirement: automated deviation detection and audit workflows (BRMS) running constantly, rather than a retrospective audit performed once a quarter, which is the difference between an audit trail that already exists and one that has to be reconstructed after the fact.
The explainability requirement is where most AI vendors will struggle
This is the sharpest edge of the coming rulebook. A lot of clinical AI on the market today is a prediction engine with no visible reasoning attached, which was tolerable when the primary audience was an internal ops team, and becomes a real liability when the audience is a regulator asking for justification. This is precisely the problem Compass Doctor was built to solve: guideline-aligned, explainable clinical reasoning rather than an opaque prescriptive output. It’s a meaningful distinction for governance purposes specifically. A system built to show its reasoning against established clinical guidelines is far closer to what regulators are asking for than a system that simply returns a score.
What to do before the requirements are final
The organizations that will handle this smoothly aren’t the ones waiting for the final rule text. They’re the ones who already run on standardized, auditable data and can show their reasoning today, because that’s a byproduct of how their systems were built, not a retrofit exercise. Avedian’s own compliance posture, spanning ISO 9001, ISO/IEC 27001, ISO/IEC 42001, SOC 2, HIPAA, and GDPR, reflects the same logic: treat auditability and explainability as core infrastructure now, and the coming mandates become a formality rather than a fire drill.
The budgets being drafted for 2027 should reflect this. The organizations asking “what will compliance cost us” are asking the wrong question a year too late. The better one is: does our current data and decision infrastructure already produce the kind of trail a regulator would accept? For most hospitals and insurers today, the honest answer is no, and that gap is exactly what’s going to show up as an unplanned line item next year.
